Recall archive / FDA company announcement

Baxter: 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container — FDA announcement Aug 25, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Aug 25, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
Reason: Potential presence of particulate matter identified as stainless steel particles in the solution.
Classification: Not supplied
Recalling firm: Baxter International Inc.
Quantity: Not supplied
Agency-reported status: Company recall announcement
Source record identifier: 6d1b691148d89678

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of 70% Dextrose Injection due to the potential presence of particulate matter identified as stainless steel particles in the solution.; The affected lot can be identified by locating the lot number and expiration date on the individual product and shipping carton, as shown in the images below.; Customers should immediately discontinue use of and return all affected units in accordance with their facility’s process. Homecare facilities who used this lot to compound parenteral nutrition solutions should contact their patients to alert them to discontinue using the solutions and replace them with ones not compounded with the affected lot. Baxter is contacting customers by email with instructions on how to identify and return the impacted product.; Product Code \| Product Description \| Lot Number \| Expiration Date \| NDC Number; 2B0296H \| 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package, Not for Direct Infusion \| Y495066 \| 31-Jul-2027 \| 0338-0719-06

Label field

Details supplied by the agency

Lot, code or applicability

FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of 70% Dextrose Injection due to the potential presence of particulate matter identified as stainless steel particles in the solution.; The affected lot can be identified by locating the lot number and expiration date on the individual product and shipping carton, as shown in the images below.; Customers should immediately discontinue use of and return all affected units in accordance with their facility’s process. Homecare facilities who used this lot to compound parenteral nutrition solutions should contact their patients to alert them to discontinue using the solutions and replace them with ones not compounded with the affected lot. Baxter is contacting customers by email with instructions on how to identify and return the impacted product.; Product Code | Product Description | Lot Number | Expiration Date | NDC Number; 2B0296H | 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package, Not for Direct Infusion | Y495066 | 31-Jul-2027 | 0338-0719-06

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product Code	Product Description	Lot Number	Expiration Date	NDC Number
2B0296H	70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package, Not for Direct Infusion	Y495066	31-Jul-2027	0338-0719-06

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Aug 25, 2026
Company announcement date: Aug 25, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

What to do next

Customers should immediately discontinue use of and return all affected units in accordance with their facility’s process. Homecare facilities who used this lot to compound parenteral nutrition solutions should contact their patients to alert them to discontinue using the solutions and replace them with ones not compounded with the affected lot. Baxter is contacting customers by email with instructions on how to identify and return the impacted product. Consumers with questions regarding this recall can contact Baxter Healthcare Center for Service at 888-229-0001 between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Read the current instructions